- Home
- Publications
- Publication Search
- Publication Details
Title
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-07-20
DOI
10.1038/s41375-018-0210-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Minimal residual hairy cell leukemia eradication with moxetumomab pasudotox: phase 1 results and long-term follow-up
- (2018) Robert J. Kreitman et al. BLOOD
- Characteristics and treatment patterns among US patients with hairy cell leukemia: a retrospective claims analysis
- (2017) Victoria Divino et al. Journal of Comparative Effectiveness Research
- Consensus guidelines for the diagnosis and management of patients with classic hairy cell leukemia
- (2016) Michael R. Grever et al. BLOOD
- Hairy cell leukemia: Past, present and future
- (2015) Bartlomiej M. Getta et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia
- (2015) Enrico Tiacci et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hairy cell leukemia: Update on molecular profiling and therapeutic advances
- (2014) Michael R. Grever et al. BLOOD REVIEWS
- Clinical characteristics and long-term outcome of young hairy cell leukemia patients treated with cladribine: a single-institution series
- (2013) J. D. Rosenberg et al. BLOOD
- Bendamustine and Rituximab in Relapsed and Refractory Hairy Cell Leukemia
- (2013) M. Burotto et al. CLINICAL CANCER RESEARCH
- Phase I Trial of Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox (CAT-8015 or HA22) in Patients With Hairy Cell Leukemia
- (2012) Robert J. Kreitman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia
- (2011) F. Ravandi et al. BLOOD
- Antibody Fusion Proteins: Anti-CD22 Recombinant Immunotoxin Moxetumomab Pasudotox
- (2011) R. J. Kreitman et al. CLINICAL CANCER RESEARCH
- Implications of minimal residual disease in hairy cell leukemia after cladribine using immunohistochemistry and immunophenotyping
- (2011) Martin S. Tallman LEUKEMIA & LYMPHOMA
- Hairy cell leukemia
- (2010) Pier Luigi Zinzani et al. CANCER
- Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis
- (2009) Monica Else et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell Leukemia
- (2009) Robert J. Kreitman et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome and toxicity in relapsed hairy cell leukemia patients treated with rituximab
- (2008) Maria K. Angelopoulou et al. LEUKEMIA & LYMPHOMA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search